Research advances in new approaches to treatment of acute-on-chronic liver failure
-
摘要:
慢加急性肝衰竭(ACLF)是临床中常见的严重肝病症候群,是我国肝衰竭中最常见的类型,内科无特效治疗手段。传统治疗方法主要包括内科综合治疗、人工肝支持系统、肝移植等。近年来,随着生物技术、细胞技术等研究的不断深入,提出了新型的人工肝支持系统、肝细胞移植、干细胞移植、集落刺激因子以及各种联合治疗方案。简述了传统的ACLF治疗方案,介绍了新技术的作用机制及其特点,并对新方案的临床应用现状、存在的问题和治疗进展进行了综述。
Abstract:Acute-on-chronic liver failure( ACLF),a severe hepatic syndrome,is the most common type of hepatic failure in China,which has no specific treatment until now. Traditional therapies mainly include comprehensive medical treatment,artificial liver support system( ALSS),and liver transplantation. In recent years,several novel approaches including new ALSS,hepatocellular transplantation,stem cell transplantation,colony stimulating factor,and combination therapies have been proposed with the constant development of biotechnologies and cytotechnologies. In the present review,the traditional therapies,as well as the mechanism and characteristics of new approaches to the treatment of ACLF,are summarized. Then,the current application,problems,and advances of these new approaches are also discussed.
-
Key words:
- liver failure /
- therapy /
- review
计量
- 文章访问数: 2641
- HTML全文浏览量: 14
- PDF下载量: 555
- 被引次数: 0